Clinical Markers of Panic and Generalized Anxiety Disorder

NCT ID: NCT06071819

Last Updated: 2023-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

290 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-01

Study Completion Date

2022-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to compare socio-demographic and clinical features in patients affected by Generalized Anxiety Disorder (GAD) and by Panic Disorder (PD). The main questions it aims to answer are:

* which socio-demographic/clinical markers are associated to GAD or PD diagnosis?
* which factors are associated with a longer duration of untreated illness (DUI) in GAD and in PD? Participants will signed a written informed consent and socio-demographic/clinical variables will be retrospectively collected. Researchers will compare GAD and PD groups in terms of socio-demographic and clinical features, including DUI, to better characterize the two disorders and to investigate factors associated to a longer DUI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Generalized Anxiety Disorder Panic Disorder Duration of Untreated Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Generalized Anxiety Disorder (GAD)

Patients affected by GAD

Structured Clinical Interview for DSM-5

Intervention Type DIAGNOSTIC_TEST

A structured interview will be administered to confirm the diagnosis reported in clinical charts

Panic Disorder (PD)

Patients affected by Panic Disorder

Structured Clinical Interview for DSM-5

Intervention Type DIAGNOSTIC_TEST

A structured interview will be administered to confirm the diagnosis reported in clinical charts

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Structured Clinical Interview for DSM-5

A structured interview will be administered to confirm the diagnosis reported in clinical charts

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-65 years;
* ability and willing to give informed consent;
* fluency in Italian language;
* diagnosis of GAD or PD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorder, 5th edition.

Exclusion Criteria

* intellectual disability;
* lack of clinical and socio-demographic information;
* patients treated for less than three months in the outpatient clinics for the impossibility of a comprehensive collection of clinical variables.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Milan

OTHER

Sponsor Role collaborator

University of Milano Bicocca

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alice Caldiroli

Psychiatrist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alice Caldiroli, Doctor

Role: PRINCIPAL_INVESTIGATOR

University of Milano Bicocca - Fondazione IRCCS San Gerardo dei Tintori

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Milano Bicocca - Fondazione IRCCS San Gerardo dei Tintori

Monza, MB, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GAD-PD-3955

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Psychodynamic Therapy for Treating Panic Disorder
NCT00128388 COMPLETED PHASE2/PHASE3